Lilly sees insurers pushing harder for discounts
Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.’s diabetes business chief says.
Health Care & Insurance
Articles
UPDATE: Lilly says it couldn’t have made tainted Cialis
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
Pence proposes $19M for Evansville medical campus
That money toward Indiana University’s portion of the project is part of $50 million that IU and other schools involved in the project have requested from the state.
UPDATE: Lilly forecasts earnings below analyst expectations
The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.
CVS to close local nutrition center with 124 workers
A division of CVS Pharmacy Inc. said it would consolidate work done at the facility to locations in Littleton, Colorado, and Jackson, Tennessee.
Hoosier hospitals create new tool to help health care shoppers
Recognizing that more and more Hoosier patients are trying to shop for health care, the Indiana Hospital Association has created a web tool with price and quality information for all hospitals around the state. But bigger changes to the health care system will be needed before consumers have the kind of information they expect in other industries.
Obamacare fees for uninsured kick in with 2014 taxes
Roughly 4 million uninsured people are expected to pay penalties, and 26 million could qualify for exemptions from a list of more than 30 waivers.
IU Health pondering new hospital in Bloomington
Indiana University Health officials are working on plans for building a new hospital in Bloomington to replace the system's aging facility.
2 IU scientists study marijuana’s impact on brain
The research is taking place as marijuana is gaining more acceptance in some parts of the nation, with pot now legalized for adult use in Colorado, Washington state, Alaska and Oregon.
Study: Nursing home building boom is costing state millions
The state Medicaid program will pay $24 million more due to the nursing home building boom that occurred in 2014, according to an analysis by accounting firm Myers & Stauffer. The nursing home industry will use that figure to once again argue for halt to new construction.
Lilly to sell heartworm line for Novartis deal approval
Eli Lilly and Co. wants to combine Novartis with its own animal health business, Elanco, to create the second-largest animal health company in the U.S.
Obamacare brings boost to WellPoint
WellPoint’s stock price rose 53 percent from Sept. 30, 2013—the day before the Obamacare insurance exchanges started up—until Dec. 19, 2014, when the price closed at $127.95.
2014 NEWSMAKER: Zeke Turner
Zeke Turner, CEO of Carmel-based Mainstreet, stepped up expansion after he beat back a legislative push by nursing home companies to place a moratorium on new construction.
Indiana again ranks 41st in U.S. health survey
While the state was strong with regards to immunizations, infectious diseases and binge drinking, it still has work to do in physical activity, obesity, and air pollution.
Conner Insurance to invest $1M, add up to 23 workers
The expansion at Keystone at the Crossing would nearly double the insurance brokerage firm's Indiana workforce to 49.
Indy hospitals stung by Medicare penalties for patient injuries
Five Indianapolis-area hospitals stand to lose more than $7 million in Medicare payments as a penalty for having rates of infections and patient injuries that run higher than most hospitals nationwide.
Zimmer to pay Stryker $70M in surgical device fight
The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
Lilly reaches insulin development deal with Adocia
Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing.
Pence: HIP 2.0 timeline not as important as approval
The state and federal government have been in negotiations since the summer, but the governor said he remains confident that an agreement will be reached, even if it isn’t by his original deadline.
Lilly bumps up dividend for first time since 2009
Shares of Eli Lilly and Co. were on the rise Tuesday morning, a day after the drugmaker announced its first dividend increase in more than five years.